VEGFA and diabetic retinopathy: Interestingly, treatment with ranibizumab and aflibercept was recently reported to decrease the severity of diabetic retinopathy, suggesting that anti-VEGF agents may help to prevent the progression of diabetic retinopathy [108,118,119,120].